[CLSTR]
< Back to situations

[ORGANIZATION]

SK Biopharm

Featured in 4 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [US] [KR] [IE]

SK Biopharm Opakalim licensing and clinical development

3 clusters · 9 sources · last updated

Latest: Biohaven faces investigation after FDA clinical hold on epilepsy drug

SK Biopharm entered an exclusive worldwide licensing agreement with Biohaven Bioscience Ireland for the epilepsy drug candidate Opakalim (BHV-7000) and its Kv7 Discovery Platform. The deal, valued at up to $795 million,

Also covered in